⌘K
Loading ticker…
Viking Therapeutics, Inc · Healthcare · Pharmaceutical Products
As of 2026-06-26, Viking Therapeutics, Inc (VKTX) has a 3-month relative strength percentile of 59 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 56. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.6%, relative volume 1.47×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
59 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
VKTX is held by 10 ETFs as of Mar 2026. Top owner: VTI at 0.01% weight, $114M notional. Top 3 carry $274M.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.01% | $114M |
| VBVanguard Small Cap ETF | 0.05% | $82M |
| XBIState Street SPDR S&P Biotech ETF | 1.04% | $77M |
| VBKVanguard Small-Cap Growth ETF | 0.12% | $46M |
| VXFVanguard Extended Market ETF | 0.05% | $42M |
| IWRiShares Russell Midcap ETF | 0.03% | $14M |
| IWDiShares Russell 1000 Value ETF | 0.01% | $7M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.01% | $5M |
| IWBiShares Russell 1000 ETF | 0.01% | $2M |
| IWFiShares Russell 1000 Growth ETF | 0.00% | $1M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | VKTX Jan avg: -3.29% median: -12.13% win: 25% σ: 22.64% n: 4 2022-04-12 → 2026-05-29 | VKTX Feb avg: 62.39% median: 21.11% win: 75% σ: 105.74% n: 4 2022-04-12 → 2026-05-29 | VKTX Mar avg: 9.37% median: 1.29% win: 50% σ: 29.42% n: 4 2022-04-12 → 2026-05-29 | VKTX Apr avg: 5.45% median: -2.95% win: 40% σ: 17.43% n: 5 2022-04-12 → 2026-05-29 | VKTX May avg: -5.52% median: -6.72% win: 40% σ: 10.63% n: 5 2022-04-12 → 2026-05-29 | VKTX Jun avg: -3.00% median: -7.99% win: 25% σ: 24.38% n: 4 2022-04-12 → 2026-05-29 (current) | VKTX Jul avg: 6.01% median: 5.84% win: 75% σ: 13.73% n: 4 2022-04-12 → 2026-05-29 | VKTX Aug avg: -0.89% median: 0.45% win: 50% σ: 12.84% n: 4 2022-04-12 → 2026-05-29 | VKTX Sep avg: -9.60% median: -8.66% win: 0% σ: 9.01% n: 4 2022-04-12 → 2026-05-29 | VKTX Oct avg: 24.71% median: 29.74% win: 75% σ: 28.81% n: 4 2022-04-12 → 2026-05-29 | VKTX Nov avg: -1.75% median: -2.28% win: 25% σ: 21.09% n: 4 2022-04-12 → 2026-05-29 | VKTX Dec avg: 38.99% median: 23.93% win: 50% σ: 69.99% n: 4 2022-04-12 → 2026-05-29 |